Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study

This publication has 14 references indexed in Scilit:

• Are randomized controlled trials sufficient evidence to guide clinical practice in Type II (non-insulin-dependent) diabetes mellitus?
  Diabetologia, 2000
• A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
  Diabetes Care, 1999
• Efficacy and safety of acarbose in the treatment of Type 2 diabetes: data from a 2-year surveillance study
  Diabetes Research and Clinical Practice, 1998
• The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance
  Experimental and Clinical Endocrinology & Diabetes, 1998
• The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance
  Diabetes Care, 1996
• Glucagon-like Peptide 1 (7-36 hide) Secretion in Response to Luminal Sucrose from the Upper and Lower Gut: A Study Using α-Glucosidase Inhibition (Acarbose)
  Scandinavian Journal of Gastroenterology, 1995
• Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
  Diabetologia, 1993
• Microbial α-Glucosidase Inhibitors: Chemistry, Biochemistry, and Therapeutic Potential
  Published by Springer Nature ,1988
• The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method
  Diabetes, 1984
• The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man
  Zeitschrift für Die Gesamte Experimentelle Medizin, 1979